Molecules/LULIZUMAB PEGOL

LULIZUMAB PEGOL

Molecular Identity

AntibodyPhase 2

Mechanism of action: T-cell-specific surface glycoprotein CD28 antagonist

Molecular Formula

0.00

Molecular Weight

g/mol

BMS-931699LULIZUMAB PEGOL

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to LULIZUMAB PEGOL

Loading drug network...